Constructing biomimetic liver models through biomaterials and vasculature engineering
Open accessThe DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index.
Abstract
The occurrence of various liver diseases can lead to organ failure of the liver, which is one of the leading causes of mortality worldwide. Liver tissue engineering see the potential for replacing liver transplantation and drug toxicity studies facing donor shortages. The basic elements in liver tissue engineering are cells and biomaterials. Both mature hepatocytes and differentiated stem cells can be used as the main source of cells to construct spheroids and organoids, achieving improved cell function. To mimic the extracellular matrix (ECM) environment, biomaterials need to be biocompatible and bioactive, which also help support cell proliferation and differentiation and allow ECM deposition and vascularized structures formation. In addition, advanced manufacturing approaches are required to construct the extracellular microenvironment, and it has been proved that the structured three-dimensional culture system can help to improve the activity of hepatocytes and the characterization of specific proteins. In summary, we review biomaterials for liver tissue engineering, including natural hydrogels and synthetic polymers, and advanced processing techniques for building vascularized microenvironments, including bioassembly, bioprinting and microfluidic methods. We then summarize the application fields including transplant and regeneration, disease models and drug cytotoxicity analysis. In the end, we put the challenges and prospects of vascularized liver tissue engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 3. Biomaterials used in the vascularized liver tissue engineering. (a) Pluronic and alginate with high applicability. Adapted with permission from Ref. [140]. (b) Collagen type I with hyaluronic acid. Adapted with permission from Ref. [149]. (c) Gelatin. (ci) Gelatin scaffolds. Adapted with permission from Ref. [71]. (cii) Photocrosslinking of GelMA, producing vascularized tissues with complex shapes. Adapted with permission from Ref. [147]. (d) dECM bioink with enhanced printability and mechanical properties. Adapted with permission from Ref. [151]. (e) Synthetic polymers. (ei) PCL mixed with biodegradable hollow fibers (HF). Adapted with permission from Ref. [156]. (eii) PLGA scaffolds. Adapted with permission from Ref. [157]. (f) Cellulose nanocrystals (CNC). Adapted with permission from Ref. [164].](https://figures.cochat.ai/paper-figures/b5f1bda8892848f788cb53e461fcdefa/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-3.jpg)
![Figure 4. Bioprinted vascularized liver models. (a) Inkjet-based bioprinting. Adapted with permission from Ref. [177]. (b) Photocuring-based bioprinting. Adapted with permission from Ref. [189]. (c) Extrusion-based bioprinting. (ci) Pre-set micro-extrusion printing. Adapted with permission from Ref. [102]. (cii) Coaxial extrusion printing. Adapted with permission from Ref. [67]. (ciii, civ) Sacrificial printing. Adapted with permission from Ref. [69, 187]. (d) Microvascular induction. (di) Microvascular induction to generate liver organoids. Adapted with permission from Ref. [103]. (dii) Microvascular induction to generate hepatic spheroids. Adapted with permission from Ref. [196].](https://figures.cochat.ai/paper-figures/42ae5d0d25a348528d9203faa4703046/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-4.jpg)
![Figure 5. Microfluidics-based vascularized liver models. (a) Liver sinusoidal fold chip. Adapted with permission from Ref. [30]. (b) Bionic liver lobule chip. Adapted with permission from Ref. [199]. (c) Fluid-coupled multiorgan chip. Adapted with permission from Ref. [201]. (d) Nonalcoholic fatty liver organ chip. Adapted with permission from Ref. [202].](https://figures.cochat.ai/paper-figures/ae37ff4fb61347ab87c782bbf9e1c64a/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-5.jpg)
![Figure 6. Applications of vascularized liver tissue. (a) Transplanted liver tissue into the liver-injured rats. Adapted with permission from Ref. [75]. (b) Drug cytotoxicity analysis. (bi) Vascularized hepatic lobular organoids for drug cytotoxicity analysis. Adapted with permission from Ref. [170]. (bii) Mechanism of action of several known hepatotoxic drugs and one experimental compound. Adapted with permission from Ref. [66]. (c) Disease models. (ci) Liver fibrosis model. Adapted with permission from Ref. [82] (cii) Cancer model [209]. (ciii) Virus transfection model. Adapted with permission from Ref. [210].](https://figures.cochat.ai/paper-figures/a5e114b550204469ab921fdad6801cdc/constructing-biomimetic-liver-models-through-biomaterials-and-vasculature-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, drug treatments may alleviate symptoms and slow disease progression but cannot fundamentally restore liver function [20–23].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Wu, Q., Li, Y., Yang, Z., Li, L., Yang, J., Zhu, X., Liu, Y., Bao, J., & Bu, H. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.10.017 · Cited by 16
Deng, S., Zhu, Y., Zhao, X., Chen, J., Tuan, R. S., & Chan, H. F. (2021) · Biofabrication · doi:10.1088/1758-5090/ac2b89 · Cited by 15
Pai, R. R., Muthusamy, S., Velayudhan, S., Arumugham, S., & Kumar, P. R. A. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28010 · Cited by 15
Development and Application of 3D Bioprinted Scaffolds Supporting Induced Pluripotent Stem Cells
Lu, D., Liu, Y., Li, W., Ma, H., Li, T., Ma, X., Mao, Y., Liang, Q., Ma, Z., & Wang, J. N. (2021) · BioMed Research International · doi:10.1155/2021/4910816 · Cited by 14
Chan, K., Fu, Y., Wu, T.-J., Hsu, P., & Lee, W. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01110.x · Cited by 13
RECENT ADVANCES IN KNOWLEDGE OF THE LIVER
Snyder, C. D. (1942) · Physiological Reviews · doi:10.1152/physrev.1942.22.1.54 · Cited by 11
Immune function of nonparenchymal liver cells
Xing, X., Wu, H., Feng, H., & Yuan, Z. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15018524 · Cited by 10
Lebersinusoide: Pathologie endothelialer Befunde
Goltz, D., & Fischer, H. (2020) · Der Pathologe · doi:10.1007/s00292-020-00802-y · Cited by 8
Photosymbiotic tissue engineering and regeneration
Maharjan, S., Bonilla, D., Orive, G., & Zhang, Y. S. (2022) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ac8a2f · Cited by 7
Park, I. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30270 · Cited by 6
[Kupffer cells and liver fibrosis].
Li, L., & Wang, B.-E. (2007) · PubMed · Cited by 3
Interactions between Hepatocytes and Liver Sinusoidal Endothelial Cells
Semela, D., & Shah, V. H. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511546198.067 · Cited by 2
Jin, W. (2011) · Shengming kexue · Cited by 1
Physiological Function and Pathological Mechanisms of Liver Sinusoidal Endothelial Cell
贺福初, 劳远翔, & 姜颖 (2012) · Cited by 1
Research works printed but not linked: 1
- He, 2016, Research on the printability of hydrogels in 3D bioprinting, Sci Rep, 6, 29977, 10.1038/srep29977 · DOI · Paper page
Cited by
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications
Huang, Y., Liu, T., Huang, Q., & Wang, Y. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00004 · Cited by 109
Self-citationLi, C., An, N., Song, Q., Hu, Y., Yin, W., Wang, Q., Le, Y., Pan, W., Yan, X., Wang, Y., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01086-7 · Cited by 67
“Furthermore, the extracellular matrix can effectively retain an array of bioactive substances, including cytokines and glycosaminoglycans, which also furnishes a viable experimental concept and foundation for the in vitro emulation of organ or cell interactions from disparate sources [136].”
BackgroundRecent progress of 3D printed vascularized tissues and organs
Zheng, K., Chai, M., Luo, B., Cheng, K., Wang, Z., Li, N., & Shi, X. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.01.001 · Cited by 60
3D printing for tissue/organ regeneration in China
He, C., He, J., Wu, C., Ruan, C., Gu, Q., Hao, Y., Wu, Y. B., Bai, S., Han, X., Ouyang, L., et al. (2025) · Bio-Design and Manufacturing · doi:10.1631/bdm.2400309 · Cited by 48
Self-citation
Metadata
- Authors
- Lv, W., Zhou, H., Aazmi, A., Yu, M., Xu, X., Yang, H., Huang, Y. Y. S., & Ma, L.
- Affiliations
- State Key Laboratory Fluid Power and Mechatronic Systems (CN)
- Zhejiang University Medical College Affiliated Stomatological Hospital (CN)
- Tongji University (CN)
- University of Cambridge (GB)
- Corresponding author
- Ma, Liang
- ORCID
- Venue
- Regenerative Biomaterials
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-01-01
- Volume
- 9
- Pages
- rbac079-rbac079
- ISSN
- 2056-3418 (ISSN-L)
- 2056-3426
- PMC
- PMC9629974
- OpenAlex
- W4304807955
- Cited by
- 45
- References
- 215
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 14 · 2023: 5
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Regenerative Biomaterials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- National Natural Science Foundation of China (51875518, 52105310, 52275294, 2018YFA0703000)
- National Key Research and Development Program of China (2018YFA0703000, 51875518)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- liver tissue engineering, biomaterials, hepatocytes, stem cells, extracellular matrix, hydrogels, synthetic polymers, bioprinting, microfluidics, liver regeneration, liver transplantation, disease models, drug toxicity testing, vascularization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.